A Case of Refractory Sézary Syndrome With Large-Cell Transformation Responsive to Brentuximab Vedotin | Dermatology | JAMA Dermatology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.153.100.128. Please contact the publisher to request reinstatement.
Observation
February 2014

A Case of Refractory Sézary Syndrome With Large-Cell Transformation Responsive to Brentuximab Vedotin

Author Affiliations
  • 1University of Massachusetts Medical School, Worcester
  • 2Department of Pathology, University of Vermont College of Medicine, Burlington
  • 3Division of Hematology/Oncology, University of Vermont College of Medicine, Burlington
  • 4Division of Dermatology, University of Vermont College of Medicine, Burlington
JAMA Dermatol. 2014;150(2):210-212. doi:10.1001/jamadermatol.2013.5741
×